Skip to main content
Clinical Trials/NCT05069532
NCT05069532
Unknown
Not Applicable

Incidence of COVID-19 Infection in Hemodialysis Patients and Predictors of Disease Complications and Mortality in Assiut University Hospital Hemodialysis Unit: A Cross-Sectional Study

Assiut University0 sites100 target enrollmentOctober 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19 Infection in Hemodialysis Patients
Sponsor
Assiut University
Enrollment
100
Primary Endpoint
Incidence of COVID-19 infection in hemodialysis patients.
Last Updated
4 years ago

Overview

Brief Summary

Dialysis patients have a higher risk of infectious complications including complications from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which causes COVID-19. There have been several reports describing the effect of CO¬VID-19 in the dialysis population.

Detailed Description

A report of hospitalized COVID-19 patients from Wuhan, China, showed that hemodialysis patients had worse outcomes compared to controls without kidney failure. In addition, the hemodialysis COVID-19 patients developed serious complications such as shock, acute respiratory distress syndrome (ARDS), arrhythmias, and acute cardiac injury at a higher rate. In a population of hospitalized dialysis patients in New York City, there was a 31% mortality rate and 75% of those who required mechanical ventilation died. These complications are due to some of their underlying comorbidities and difficulties of keeping adequate social distancing as recommended by CDC guidelines. We aim to identify all hemodialysis patients who will be admitted from October 1, 2021 to Septemper 30, 2022. Patients who tested positive for COVID-19 by a polymerase chain reaction (PCR) or highly suspected (CORAD 4-5) according to radiological finding, will be selected and followed until discharge from hospital to determine who will develop complications and who will need ventilatory support. Also, the rate of death will be monitored. Therefore, the current study is aiming to better understand the hemodialysis patients' characteristics profile that makes them susceptible for complications and death.

Registry
clinicaltrials.gov
Start Date
October 1, 2021
End Date
March 31, 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Aboelfatouh Tantawy

principal investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • All hemodialysis patients who defined as patient receiving maintenance dialysis prior to admission and diagnosed with COVID-19 infection either highly suspicious radiological findings (CORAD 4-5) or proved by PCR for COVID-19.

Exclusion Criteria

  • ALL Patients diagnosed COVID-19 other than hemodialysis patients.
  • Hemodialysis patients with chest infection other than COVID-19.

Outcomes

Primary Outcomes

Incidence of COVID-19 infection in hemodialysis patients.

Time Frame: 1 year

radiological and laboratory findings on MSCT chest \& PCR respectively.

Similar Trials